Posterior iris-claw aphakic IOL implantation and DMEK (Ocular pathology and comorbidities)
| Patient No. | Age (years)/Gender | Eye | Surgery | Ocular pathology | Ocular co-morbidities |
|---|---|---|---|---|---|
| 1 | 83/M | L | DMEK+secondary retropupillar iris-claw IOL | Aphakic, 10 months after complicated cataract surgery | Dry age-related macular degeneration |
| 2 | 83/F | R | DMEK+IOL exchange | Anterior subluxated Sulcus-IOL, 23 years after traumatic cataract surgery | – |
| 3 | 70/F | L | DMEK+IOL exchange | 15 years after ACIOL | Previous pars plana vitrectomy with gas tamponade after retinal detachment in 1995 |
| 4 | 84/F | R | DMEK+IOL exchange | 18 years after ACIOL | Severe exsudative age-related macular degeneration following 17 intravitreal injections of ranibizumab |
| 5 | 79/F | L | DMEK after IOL exchange | 4 months after failed DSAEK, 4 years after ACIOL removal and retropupillar iris-claw IOL implantation | – |
| 6 | 80/F | L | DMEK after IOL exchange | 6 months after IOL exchange (retropupillar iris-claw IOL) due to dislocated PCIOL | – |
| 7 | 67/M | L | DMEK (+intravitreal 4 mg Triamcinolon) after IOL exchange | 12 months after IOL exchange (retropupillar iris-claw IOL) due to bullous keratopathy after secondary implantation of an anterior iris-claw IOL after complicated cataract surgery in 2004 | Cystoid macular oedema, secondary glaucoma, pseudoexfoliation syndrome |
AC, anterior chamber; DMEK, Descemet membrane endothelial keratoplasty; DSAEK, Descemet stripping automated endothelial keratoplasty; F, female; IOL, intraocular lens; L, left; M, male; PC, posterior chamber; R, right.